HealthTree Logo
search more_vert
person Sign In / Create Account

Emmanuel Katsanis, MD

Director of the Hematopoietic Cellular Therapy and Transplant Program (adult and pediatric) and Division Chief of Pediatric Hematology/Oncology

34 years treating Acute Myeloid Leukemia

Clinical Expertise

Dr. Katsanis's laboratory has established various experimental haploidentical hematopoietic cell transplantation (HHCT) models and is studying novel conditioning regimens and agents that can be applied following transplantation to limit graft versus host disease (GvHD) while permitting donor chimerism, immune reconstitution and graft versus tumor effects. The mechanisms of action of these regimens are being investigated in leukemia and solid tumor models. His lab's objective is the translation of innovative HHCT approaches into Phase I/II trials for pediatric and adult patients with advanced hematologic malignancies and refractory solid tumors.


University Of Arizona Cancer Center: 3838 N Campbell Ave, Tucson, AZ 85719, USA

Get the latest thought leadership on Acute Myeloid Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Acute Myeloid Leukemia Newsletter" for Acute Myeloid Leukemia news, life with Acute Myeloid Leukemia stories, Acute Myeloid Leukemia clinical trials, Acute Myeloid Leukemia 101 articles and events with Acute Myeloid Leukemia experts.

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Astellas Pharma

Follow Us

facebook twitter